124 related articles for article (PubMed ID: 29198054)
1. A case of unusually long survival after leptomeningeal carcinomatosis diagnosis.
Riolo M; Ciusani E; Salmaggi A
J Neurooncol; 2018 Mar; 137(1):215-218. PubMed ID: 29198054
[No Abstract] [Full Text] [Related]
2. Implication of breast cancer phenotype for patients with leptomeningeal carcinomatosis.
Torrejón D; Oliveira M; Cortes J; Sanchez-Olle G; Gómez P; Bellet M; Saura C; Peg V; Rovira A; Di Cosimo S
Breast; 2013 Feb; 22(1):19-23. PubMed ID: 23137566
[TBL] [Abstract][Full Text] [Related]
3. Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities.
Kak M; Nanda R; Ramsdale EE; Lukas RV
J Clin Neurosci; 2015 Apr; 22(4):632-7. PubMed ID: 25677875
[TBL] [Abstract][Full Text] [Related]
4. Prolonged overall survival of patients with leptomeningeal carcinomatosis from nonsmall cell lung cancer.
Ju Y; Sun S; Wang J; Jiao S
J Cancer Res Ther; 2016 Oct; 12(Supplement):126-129. PubMed ID: 27721269
[TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal carcinomatosis in esophageal cancer: a case series and systematic review of the literature.
Lukas RV; Mata-Machado NA; Nicholas MK; Salgia R; Antic T; Villaflor VM
Dis Esophagus; 2015; 28(8):772-81. PubMed ID: 25142531
[TBL] [Abstract][Full Text] [Related]
6. Leptomeningeal Carcinomatosis Associated with Gall Bladder Carcinoma: a Case Report and Review of Literature.
Khan TH; Veer M; Bilal M; Curran-Melendez S; Jani PM; Long GS
J Gastrointest Cancer; 2019 Jun; 50(2):315-319. PubMed ID: 28913746
[No Abstract] [Full Text] [Related]
7. Characteristics and outcomes of non-Hodgkin's lymphoma patients with leptomeningeal metastases.
Meng X; Yu J; Fan Q; Li L; Li W; Song Z; Liu X; Jiang Y; Gao M; Zhang H
Int J Clin Oncol; 2018 Aug; 23(4):783-789. PubMed ID: 29558001
[TBL] [Abstract][Full Text] [Related]
8. In a Patient With Cancer, Not All That Enhances Is Leptomeningeal Carcinomatosis.
Sindhu KK; Chang S; Liu J; Bakst RL; Dharmarajan KV
J Oncol Pract; 2019 Oct; 15(10):558-559. PubMed ID: 31600463
[No Abstract] [Full Text] [Related]
9. Management of leptomeningeal carcinomatosis and challenges of trial design.
Gill CM; Brastianos PK
Curr Opin Oncol; 2019 Nov; 31(6):508-513. PubMed ID: 31503030
[TBL] [Abstract][Full Text] [Related]
10. Newer avenues for the treatment of leptomeningeal carcinomatosis.
Meriggi F; Zaniboni A
Cent Nerv Syst Agents Med Chem; 2011 Mar; 11(1):38-44. PubMed ID: 21250935
[TBL] [Abstract][Full Text] [Related]
11. Meningeal carcinomatosis in solid tumors.
Martins SJ; Azevedo CR; Chinen LT; Cruz MR; Peterlevitz MA; Gimenes DL
Arq Neuropsiquiatr; 2011 Dec; 69(6):973-80. PubMed ID: 22297890
[TBL] [Abstract][Full Text] [Related]
12. The necessity of intrathecal chemotherapy for the treatment of breast cancer patients with leptomeningeal metastasis: A systematic review and pooled analysis.
Lee YC; Hsieh CC; Chuang JP; Li CY
Curr Probl Cancer; 2017; 41(5):355-370. PubMed ID: 28779849
[TBL] [Abstract][Full Text] [Related]
13. Leptomeningeal Myelomatosis: A Rare but Devastating Manifestation of Multiple Myeloma Diagnosed Using Cytology, Flow Cytometry, and Fluorescent in situ Hybridization.
Bommer M; Kull M; Teleanu V; Schwarzwälder P; Feuring-Buske M; Kroenke J; Bunjes D; Langer C
Acta Haematol; 2018; 139(4):247-254. PubMed ID: 29996124
[TBL] [Abstract][Full Text] [Related]
14. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of leptomeningeal carcinomatosis in 4 cases].
Bao J; Hu XQ; Jiang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):2047-9. PubMed ID: 19033125
[TBL] [Abstract][Full Text] [Related]
16. Leptomeningeal carcinomatosis: prognostic value of clinical, cerebrospinal fluid, and neuroimaging features.
Palma JA; Fernandez-Torron R; Esteve-Belloch P; Fontes-Villalba A; Hernandez A; Fernandez-Hidalgo O; Gallego Perez-Larraya J; Martinez-Vila E
Clin Neurol Neurosurg; 2013 Jan; 115(1):19-25. PubMed ID: 22534095
[TBL] [Abstract][Full Text] [Related]
17. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.
Lee SJ; Lee JI; Nam DH; Ahn YC; Han JH; Sun JM; Ahn JS; Park K; Ahn MJ
J Thorac Oncol; 2013 Feb; 8(2):185-91. PubMed ID: 23328548
[TBL] [Abstract][Full Text] [Related]
18. Dysphagia and anorexia as presentations of leptomeningeal carcinomatosis.
Aiyer R; Engelman E; Xue W; Yu E
BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27073151
[TBL] [Abstract][Full Text] [Related]
19. Primary glioblastoma multiforme of the conus medullaris with leptomeningeal metastasis.
Nunn A; Polyzoidis S; Piechowski-Jozwiak B; Brazil L; Ashkan K
J Neurol Sci; 2017 Oct; 381():315-317. PubMed ID: 28991705
[No Abstract] [Full Text] [Related]
20. Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis.
Subirá D; Simó M; Illán J; Serrano C; Castañón S; Gonzalo R; Granizo JJ; Martínez-García M; Navarro M; Pardo J; Bruna J
Clin Exp Metastasis; 2015 Apr; 32(4):383-91. PubMed ID: 25795393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
